Name: mrsa: host adaptation and transmission
Uploaded: 2026-03-12T13:36:05.000Z
Duration: 1 min 25 s
Channel: JoVE

항생제 내성은 미생물이 항생제의 효과를 견딜 수 있는 능력을 말합니다.일반적으로 알려진 병원체인 황색포도상구균(Staphylococcus aureus)은 메티실린에 내성을 발달시켜 메티실린 내성 황 색포도상구균(MRSA)을 형성했습니다.MRSA는 인간에게 심각한 피부 및 연부 조직 감염을 일으켜 매년 전 세계적으로 수백만 명의 입원과 사망을 초래합니다.노인과 면역억제 환자들은 광범위 항생제의 장기간과 광범위한 사용으로 인해 가장 높은 위험에 노출됩니다.MRSA와 싸우기 위한 전략으로는 식물화학물질, 파지 치료, 나노입자, 프로바이오틱스 등이 포함됩니다.식물에서 추출한 2차 대사산물인 식물화학물질은 MRSA 성장을 억제하는 데 널리 사용됩니다.MRSA 특이적 파지는 세포 용해를 유도하여 MRSA 개체군을 줄일 수 있습니다.나노입자는 세포 내에서 중금속 이온을 방출하여 스트레스를 가합니다. 막 투과성을 변화시키고 필수 세포 기능을 방해합니다.마지막으로, 일부 프로바이오틱 품종은 MRSA 성장을 억제하는 항생제 화합물을 분비합니다.

항생제 내성의 임상적 의의

Clinical Significance of Antibiotic Resistance

메티실린 내성 황색포도상구균 (MRSA)은 포도상구균 카세트 염색체 MEC(SCCmec) 내 mecA 유전자를 획득함으로써 β락탐 항생제에 저항하는 능력으로 인해 심각한 공중보건 위협을 제기합니다. 이 유전자는 메티실린 및 기타 β락탐의 결합 효능을 저하시키는 페니실린 결합 단백질 2a(PBP2a)를 암호화합니다. MRSA는 인간과 동물 모두에게 영향을 미치는 뚜렷한 클론 계통으로 진화하여 One Health 패러다임 내에서 그 중요성을 더욱 강화하고 있습니다.MRSA 균주는 의료 관련 바이러스(HA-MRSA), 지역사회 관련 균주(CA-MRSA), 가축 관련 균주(LA-MRSA)로 분류됩니다. 이 계통들은 클론 복합체(CC) 변이와 숙주 특이성을 보입니다. 예를 들어, CC398은 원래 인간에서 유래했으나 가축, 특히 돼지에서 적응하여 역인수공통전파가 이루어지고 있습니다. CC1, CC5, CC8, CC97과 같은 여러 CC가 숙주 종 전반에 걸쳐 확인되었으며, 이는 복잡한 종간 유전자 흐름과 환경 적응과 관련이 있음을 시사합니다.MRSA의 전 세계적 유병률은 매우 다양합니다. 예를 들어, CA-MRSA는 일본에서 분리주의 79%를 차지하는 반면, LA-MRSA는 말레이시아 낙농용 소의 최대 38.6%에서 검출되었습니다. 동물 내 LA-MRSA 정착은 특히 농부나 수의사 등 밀접한 접촉자들에게 인수공통전적 위험을 초래합니다. 보고서들은 반려동물과 인간 간 전염 사건이 확인되어 통합 감시의 필요성을 강조하고 있습니다.MRSA의 병원성은 MSCRAMM, 장독소, 판톤-발렌타인 백고시딘(PVL) 등 다양한 병원성 인자에 의해 결정됩니다. 바이오필름 형성과 페놀 용해 모듈린은 지속적인 저항과 면역 회피를 더욱 촉진합니다. SaPIbov와 같은 병원성 섬과 mecC 를 보유한 SCCmec type XI와 같은 이동성 유전 요소는 숙주 적응에 매우 중요합니다. 더불어, 소에 적응한 균주에서 많이 발현되는 lukMF' 독소는 낙농용 소에서 유선염의 심각도를 악화시킵니다.반코마이신과 댑토마이신 등 전통적인 항생제가 여전히 주요 치료법이지만, 내성이 증가하고 있습니다. 테디졸리드와 델라플로록사신과 같은 새로운 항생제와 식물화학물질, 프로바이오틱스, 나노입자, 박테리오파지 등 비항생제 접근법들이 가능성을 보여줍니다. 특히, 녹색 합성 은 나노입자와 락 토바실러스 및 비피도박테리움 의 프로바이오틱 균주가 MRSA에 대해 유의미한 시험관 내 효능을 보였습니다

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist &#946;-lactam antibiotics ...

https://cloudfront.jove.com/files/ftp_upload/40867/40867_article_thumb_40867.jpg

clinical-significance-of-antibiotic-resistance

Education

교육

JoVE Core

Microbiology

미생물학

Unit

단위

Antimicrobial Agents

항균제

KEY TERMS AND CONCEPTS

주요 용어 및 개념

mrsa: host adaptation and transmission

MRSA, or methicillin-resistant Staphylococcus aureus, is a major public health threat. It resists beta-lactam antibiotics because it carries the mecA gene inside the staphylococcal cassette chromosome mec, or SCCmec. The mecA gene makes penicillin-binding protein 2a, which reduces how well methicillin and related beta-lactam drugs can bind.

MRSA has spread into separate clonal lineages that affect both humans and animals. These lineages fit the One Health idea, which links human, animal, and environmental health. MRSA is often grouped as healthcare-associated MRSA, community-associated MRSA, and livestock-associated MRSA. These groups also show different clonal complexes and host preferences.

One example is CC398. It began in humans, then adapted to livestock, especially pigs, and later spread back from animals to people. Other clonal complexes, including CC1, CC5, CC8, and CC97, have been found across host species. This pattern shows gene flow between species and adaptation to different environments.

MRSA prevalence also differs by region and host. Community-associated MRSA makes up 79% of isolates in Japan. Livestock-associated MRSA has been found in up to 38.6% of dairy cattle in Malaysia. Because LA-MRSA can colonize animals, it can also pose a zoonotic risk to people who work closely with them, such as farmers and veterinarians.

Transmission has also been reported between pets and humans. These findings show why integrated surveillance matters. MRSA pathogenicity is driven by virulence factors such as MSCRAMMs, enterotoxins, and Panton-Valentine leukocidin, or PVL. Biofilm formation and phenol-soluble modulins also help the bacteria persist and avoid immune attack.

Mobile genetic elements are important in host adaptation. SaPIbov and SCCmec type XI, which carries mecC, are examples. In bovine-adapted strains, the lukMF' toxin is strongly expressed and can worsen mastitis in dairy cattle. These features help explain how MRSA survives in different hosts and disease settings.

Treatment still relies on antibiotics such as vancomycin and daptomycin, but resistance is increasing. Newer drugs, including tedizolid and delafloxacin, may offer more options. Non-antibiotic strategies are also being studied, including phytochemicals, probiotics, nanoparticles, and bacteriophages. Green-synthesized silver nanoparticles and probiotic strains of Lactobacillus and Bifidobacterium have shown promising results against MRSA in laboratory studies.

MRSA: Host Adaptation and Transmission

inhibitors of gram-positive cell wall synthesis

inhibitors-of-gram-positive-cell-wall-synthesis

How Antibiotics Block Bacterial Cell Walls

Bacterial cell walls are rigid structures built mainly from peptidoglycan. This mesh-like polymer gives bacteria strength and helps maintain cell shape. Because peptidoglycan synthesis is essential for growth, it is a major target for antibiotics. Beta-lactam antibiotics, such as penicillin, stop peptidoglycan synthesis in actively growing cells. They have a four-membered beta-lactam ring that mimics the D-alanyl-D-alanine dipeptide, which is the natural substrate for transpeptidase, also...

inhibitors of bacterial protein synthesis

inhibitors-of-bacterial-protein-synthesis

Aminoglycosides: How They Stop Bacteria

Aminoglycosides are bactericidal antibiotics that stop bacteria by targeting the ribosome and disrupting protein synthesis. They are highly potent drugs made of amino-modified sugars linked by glycosidic bonds to an aminocyclitol core, such as 2-deoxystreptamine or streptamine. Their strong positive charge helps them bind tightly to the negatively charged phosphate backbone of ribosomal RNA, especially the 16S rRNA of the 30S subunit in the bacterial 70S ribosome. These antibiotics act at the...

inhibitors of bacterial dna synthesis

Fluoroquinolone Antibiotics and Bacterial DNA

Fluoroquinolone antibiotics target bacterial DNA replication by blocking two key type II topoisomerases: DNA gyrase and topoisomerase IV. These enzymes help bacteria manage DNA supercoiling and separate chromosomes during replication. When they are disrupted, bacterial pathogens cannot copy DNA efficiently and infection can spread less effectively. Fluoroquinolones are synthetic versions of quinolones. They work by stabilizing the short-lived DNA-enzyme cleavage complex, which stops strand...

inhibitors of viral protein synthesis

Interferons Block Viral Replication

Interferons block viral replication by shutting down protein synthesis and activating the cell’s antiviral defenses. Viruses need the host cell’s translational machinery to make proteins, because they do not have the machinery to do this on their own. When a virus is detected, infected cells release interferons, which are cytokines, or signaling proteins, that warn nearby uninfected cells. Interferons bind to receptors on nearby cells and activate the JAK-STAT signaling pathway. This turns on...

inhibitors of virion release

Neuraminidase Inhibitors and Flu Spread

Influenza viruses spread when new virions leave an infected cell and reach nearby cells. Influenza A and B are negative-sense, single-stranded RNA viruses with segmented genomes. They depend on two surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA), to infect cells, make new viral particles, and release them. HA starts infection by binding to sialic acid on the surface of host epithelial cells. This binding helps the virus enter the cell by receptor-mediated endocytosis. After...

antiviral nucleoside inhibitors

How Antiviral Drugs Stop Viral Replication

Antiviral nucleoside inhibitors stop viruses by blocking DNA or RNA synthesis. These drugs are structural analogs, which means they look like natural nucleosides, the building blocks cells use to make genetic material. Because they resemble host nucleosides, they can interfere with viral polymerases and disrupt viral genome replication. Acyclovir is a guanosine analog with a three-carbon acyclic side chain. It mainly targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2...

antifungal agents

Amphotericin B and Fungal Membranes

Amphotericin B targets fungal cell membranes by binding to ergosterol, a sterol found mainly in fungal plasma membranes. Its amphipathic structure helps this selective binding. It has a hydrophobic polyene-lactone ring and a hydrophilic region with mycosamine and carboxylic acid groups. Weak binding to cholesterol can also affect human cells and helps explain the drug’s toxicity. One way amphotericin B kills fungi is through pore formation. In this model, amphotericin B-ergosterol complexes...

mechanism of antibiotic resistance in mrsa

mechanism-of-antibiotic-resistance-in-mrsa

How Bacteria Outsmart Antibiotics

Antibiotic resistance in bacteria happens when microbes evolve the ability to survive drugs that once killed them or slowed their growth. Genetic change and antibiotic exposure drive this process. Over time, useful treatments can stop working. Bacteria can resist antibiotics in several ways. Some make drug-inactivating enzymes, such as beta-lactamases. Others use efflux pumps to push antibiotics out of the cell. Resistance can also come from mutations that change the drug target, from lower...

anthelminthic agents

Helminth Drugs and How They Work

Helminth drugs work by attacking the weak points of parasitic worms. These anthelmintic medicines are different from drugs used against protozoa, because they are usually aimed at mature helminths rather than fast-dividing cells. They target the worm’s movement, glucose use, and microtubule structure to stop survival, reproduction, and location inside the host. Benzimidazoles are broad-spectrum anthelmintics that block tubulin polymerization, which means they interfere with microtubules, the...

clinical significance of antibiotic resistance

MRSA, or methicillin-resistant Staphylococcus aureus, is a major public health threat. It resists beta-lactam antibiotics because it carries the mecA gene inside the staphylococcal cassette chromosome mec, or SCCmec. The mecA gene makes penicillin-binding protein 2a, which reduces how well methicillin and related beta-lactam drugs can bind. MRSA has spread into separate clonal lineages that affect both humans and animals. These lineages fit the One Health idea, which links human, animal, and...

inhibitors of virion maturation and assembly

inhibitors-of-virion-maturation-and-assembly

HIV Protease Inhibitors and Maturation

HIV protease inhibitors block a key step in virus maturation. In human immunodeficiency virus (HIV), infected cells make two long precursor proteins called polyproteins. These are Gag and Gag-Pol. Gag provides the virus structure. Gag-Pol carries important viral enzymes, including reverse transcriptase, integrase, and protease. After these polyproteins are made, they move to the host cell membrane. There, they help build an immature viral particle that buds from the cell surface. Budding...

antiprotozoal agents

Leishmaniasis and Trypanothione Reductase

Leishmaniasis is a parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. Treatment often relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. The way these drugs work has not been fully clear. One important target is trypanothione reductase, or TR, an enzyme that helps keep Leishmania in redox balance. TR is not found in mammalian hosts, so it is a...

key terms and concepts

Learn how MRSA spreads between humans and animals, why it resists beta-lactam antibiotics, and what treatments and new control methods are being studied.

MRSA: Host Adaptation and Transmission | JoVE K12

JoVE Core Microbiology provides an engaging introduction to the microbial world and its influence on health, industry, and the environment. This comprehensive collection covers key concepts such as microbial structure, metabolism, genetics, and ecology. It introduces essential laboratory techniques and microscopy methods through visually engaging animations. Corresponding scientist-in-action videos bridge classroom concepts with real-world research and applications.

microbiology

MRSA: Host Adaptation and Transmission

Description

Transcript

Tags